Thrombin Elaboration in Endotoxin-Induced intravascular Fibrin Deposition

Summary

Intravascular coagulation was induced by two appropriately spaced doses of endotoxin and by infusion of thromboplastin. The resulting fibrin deposition was measured by a previously described quantitative technique. Evidence of thrombin elaboration was obtained indirectly by measurement of fibrin monomer (FM) and by the detection and isolation of a thrombin-induced anticlotting activity. Venous segments were isolated at intervals and examined for thrombus formation following 40 minutes of stasis. Endotoxin triggered thrombin elaboration was not detectable in the circulation for at least one hour and was not accompanied by any thrombosis in isolated venous segments. No thrombin elaboration was found in leukopenic rabbits given endotoxin. In the thromboplastin infused animals, the quantity of fibrin deposited in the organs was comparable to that found after endotoxin. However, thrombin was found in the blood immediately and was associated with thrombosis in the isolatet venous segments. Less thrombin-induced anticoagulant activity was found after thromboplastin than after endotoxin. The findings suggest that endotoxin-induced intravascular coagulation is probably not caused by a mechanism of systemic hypercoagulability due to the release of thromboplastic material into the blood stream. A focal process of thrombin elaboration involving leukocytes is postulated. The study is believed relevant to patients with disseminated intravascular coagulation in whom venous thromboembolism is rarely found despite evidence of extensive microvascular fibrin deposition.

• References

• 1 Chang M. S, Wilson R. E, Frenkel E. P. 1974; Soluble fibrin complexes in experimental thrombotic states. Journal of Laboratory and Clinical Medicine 84: 168.
• 2 Good R. A, Thomas L. 1953; Studies on the generalized Shwartzman reaction. IV. Prevention of the local and generalized Shwartzman reaction with heparin. Journal of Experimental Medicine 97: 871.
• 3 Gurewich V, Hutchinson E. 1971; Detection of intravascular coagulation by the serial dilution protamine sulfate test. Annals of Internal Medicine 75: 895.
• 4 Gurewich V, Lipinski B, Lipinska I. 1973; Comparative study of precipitation and paracoagulation by protamine sulfate and ethanol gelation tests. Thrombosis Research 2: 539.
• 5 Gurewich V, Lipinski B. 1976; Semi quantitative determination of soluble fibrin monomer complexes by chromatography and serial dilution protamine sulfate test. American Journal of Clinical Pathology 65: 397.
• 6 Gurewich V, Lipinski B, Wetmore R. 1976; A study of the large heparin requirements in the generalized Shwartzman reaction. Blood 47: 297.
• 7 Gurewich V. and Lipinski, B. Unpublished observations.
• 8 Hyde E, Wetmore R, Gurewich V. 1974; Isolation and characterization of an in vivo thrombin-induced anticoagulant activity. Scandinavian Journal of Hematology 13: 121.
• 9 Lipinski B, Nowak A, Gurewich V. 1974; The organ distribution of ¹²⁵I-fibrin in the generalized Shwartzman reaction and its relation to leukocytes. British Journal of Hematology 28: 221.
• 10 Lipinski B, Gurewich V. 1976; The effect of leukopenia versus thrombocytopenia on endotoxin-induced intravascular coagulation. Thrombosis Research 8: 403.
• 11 Marciniak E. 1972; Inhibitor of human blood coagulation elicited by thrombin. Journal of Laboratory and Clinical Medicine 79: 924.
• 12 McFarlane A. S. 1958; Efficient trace-labelling of proteins with iodine. Nature 182: 53.
• 13 McKay D. G. 1966. Blood coagulation and the generalized Shwartzman reaction. In: Brinkhous K. M, Wright J. S, Koller F, Streich F, Dcukert F. (eds.). Diffuse Intravascular Clotting. F. K. Schattauer-Verlag; Stuttgart: 107.
• 14 Niemetz J, Fani K. 1971; Role of leukocytes in blood coagulation and the generalized Shwartzman reaction. Nature 232: 247.
• 15 Niemetz J. 1972; Coagulant activity of leukocytes. Tissue factor activity. Journal of Clinical Investigation 51: 307.
• 16 Niewiarowski S, Gurewich V. 1971; Laboratory identification of intravascular coagulation: the serial dilution protamine sulfate test for the detection of fibrin monomer and fibrin degradation products. Journal of Laboratory and Clinical Medicine 77: 65.
• 17 Pitlick F. A, Nemerson Y, Gottlieb A. J, Gordon R. G, Williams W. J. 1971; Peptidase activity associated with the tissue factor of blood coagulation. Biochemistry 10: 2650.
• 18 Robboy S. J, Colman R. W, Minna J. D. 1972; Pathology of disseminated intravascular coagulation (DIC). Analysis of 26 cases. Human Pathology 3: 327.
• 19 Stetson C. A, Good R. A. 1951; Studies on the mechanism of the Shwartzman phenomenon. Evidence for the participation of polymorphonuclear leukocytes in the phenomenon. Journal of Experimental Medicine 93: 49.
• 20 Swaim W. R, Feders M. B. 1967; Fibrinogen assay. Clinical Chemistry 13: 1026.
• 21 Wessler S, Reimer S. M, Sheps M. C. 1959; Biologic assay of a thrombosis-inducing activity in human serum. Journal of Applied Physiology 14: 943.
• 22 Wetmore R, Gurewich V. 1974; The role of fibrin monomer and an in vivo thrombin-induced anticoagulant in experimental venous thrombosis. Scandinavian Journal of Hematology 12: 204.